SCHEMBL3754215

SCHEMBL3754215

Cc1ccc(Cl)cc1Oc1nc(-c2cccc(F)c2F)ccc1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
SCN9A Q15858 4/20 0.39
EIF4E P06730 1/20 0.39
SORT1 Q99523 1/20 0.39
DHODH Q02127 1/20 0.38
PTGER1 P34995 3/20 0.38
PTGER4 P35408 2/20 0.38
SCN8A Q9UQD0 1/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
KMO O15229 2/20 0.36
PYGL P06737 1/20 0.36
PYGM P11217 1/20 0.36
CTSA P10619 1/20 0.36
GRIK1 P39086 1/20 0.36
TBXA2R P21731 1/20 0.36
PTGER3 P43115 1/20 0.36
HSD17B14 Q9BPX1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753803 0.86 ALDH1A1 (0.43) KDM4EALDH1A1HPGDEIF4EDHODH
SCHEMBL3758001 0.84 PLAU (0.43) KDM4EALDH1A1HPGDEIF4EDHODH
SCHEMBL3750445 0.83 EIF4E (0.43) KDM4EALDH1A1HPGDSCN9AEIF4E
SCHEMBL3755130 0.83 KMO (0.44) KDM4EALDH1A1HPGDEIF4EDHODH
SCHEMBL3757716 0.83 EIF4E (0.39) KDM4EALDH1A1HPGDEIF4EDHODH
SCHEMBL3753505 0.82 ALDH1A1 (0.43) KDM4EALDH1A1HPGDEIF4EDHODH
SCHEMBL3752610 0.82 PDE2A (0.38) KDM4EALDH1A1HPGDSCN9APTGER1
SCHEMBL3762159 0.80 KDM4E (0.42) KDM4EHPGDEIF4EPYGLPYGM
SCHEMBL3754181 0.80 PLG (0.43) KDM4EEIF4EKMOPYGLPYGM
SCHEMBL3759586 0.79 HTT (0.47) KDM4EALDH1A1HPGDDHODHCTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 KDM4E 1949/4885ALDH1A1 1855/4885HPGD 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.